Have a personal or library account? Click to login
Serum Oxidative Stress Markers are not Associated with Renal and Common Carotid Arteries Arteriosclerotic Vascular Changes in Patients with Gout Cover

Serum Oxidative Stress Markers are not Associated with Renal and Common Carotid Arteries Arteriosclerotic Vascular Changes in Patients with Gout

Open Access
|Oct 2019

References

  1. 1. Krishnan E. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 2010; 49(7):1229-38.10.1093/rheumatology/keq03720202928
  2. 2. Yang X, Li Y, Ren X et al. Oxidative stress – Mediated Atherosclerosis: Mechanisms and Therapies. Front Physiol. 2017;8:600. doi: 10.3389/fphys.2017.0060.10.3389/fphys.2017.00600
  3. 3. Wilcox C, Araujo M. Antioxid. Redox Signal. 2014, 2011(1):74-101.10.1089/ars.2013.5259
  4. 4. Nageswara R, Vendrov MA, Runge MS. Oxidative stress and vascular disease. Atherosclerosis, Thrombosis and Vascular biology. 2005; 25:29-38.10.1161/01.ATV.0000150649.39934.1315539615
  5. 5. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008; 27(6):608-619.10.1080/15257770802138558
  6. 6. Neogi T, Jansen TLT, Dalbeth N et al. Gout classification criteria. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheumatol 2015; 67:2557-2568.10.1002/art.39254456615326352873
  7. 7. Shi H, Sui Y, Wang X et al. Hydroxyl radical production and oxidative damage induced by cadmium and naphthalene in liver of Carassius auratus Comp. Biochem and Physiol. Part C: Toxicol and Pharmacol. 2005; 140:115-121.10.1016/j.cca.2005.01.009
  8. 8. Yoshioka T, Iwamoto N. Ito K. An application of Electron Paramagnetic Resonance to evaluate nitric oxide and its quenchers. J Am Soci Nephrol. 1996;7:961-965.10.1681/ASN.V769618793807
  9. 9. Yokoyama K, Hashiba K, Wakabayashi H et al. Inhibition of LPS-stimulated NO production in mouse macrophage-like cells by Tropolones. Anticans res. 2004; 24:3917-3922.
  10. 10. Viazzi F, Leoncini G, Derchi LE, Pontremoli R. Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 2014; 32:149-153.10.1097/HJH.0b013e328365b29c386802624172238
  11. 11. Staub D, Meyerhans A, Bundi B et al. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 2006; 37:800-805.10.1161/01.STR.0000202589.47401.c616439703
  12. 12. Frauchinger B, Schmid HP, Roedel C et al. Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 2001; 32:836-841.10.1161/01.STR.32.4.836
  13. 13. Cippoli JA, Ferreira-Sae MC, Martins RP et al. Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovascular Disorders. 2012;12:52. doi 10.1186/1471-2261-12-52.10.1186/1471-2261-12-52341819322800461
  14. 14. Montalcini T, Gorgone G, Gazzaruso C, et al. Relation between serum uric acid and carotid intima-meida thickness in healthy postmenopausal women. Intern Emerg Med. 2007; 2(1):19-23.10.1007/s11739-007-0004-3278060617551679
  15. 15. Tavil Y, Kaya MG, Oktar SO, et al. Uric acid level and its association with intima-media thickness in patients with hypertension. Atherosclerosis. 2008; 197(1):159-163.10.1016/j.atherosclerosis.2007.03.00817416371
  16. 16. Messerli F, Christie B, de Carvalho JGR, et al. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980; 93(6):817-821.10.7326/0003-4819-93-6-8177447188
  17. 17. Çukurova S, Pamuk ÖN, Ünlü E, et al. Subclinical atherosclerosis in gouty arthritis patients: a comparative study. Rheumatol Int. 2012; 32(6):1769-73.10.1007/s00296-011-1900-421442166
  18. 18. Gancheva R, Koundurdjiev A, Ivanova M et al. Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography. Rheumatol Int. 2017; 37(1):121-130.10.1007/s00296-016-3556-627577941
  19. 19. Schulz E, Gori T, Muntel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 2011; 34: 665-73.10.1038/hr.2011.3921512515
  20. 20. Bake JR, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118(8):816-26.10.1016/j.amjmed.2005.03.043
  21. 21. Neogi T, George J, Rekhraj S et al. Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal. Arthritis Rheum. 2012;64(2):327-38.10.1002/art.33369326568321953377
  22. 22. Corry DB, Eslami P, Yamamoto K et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renini-angiotensin system. J. Hypertens 2008; 26:269-75.10.1097/HJH.0b013e3282f240bf18192841
  23. 23. Kato M, Hisatone I, Tomikura Y, et al. Status of endothelial dependent vasodilatation in patients with hyperuricemia. Am. J Cardiol 2005; 96:1576-8.10.1016/j.amjcard.2005.07.06816310444
  24. 24. Patterson RA, Horsley ET, Leake DS. Prooxidant and anti-oxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J Lipid Res 2003; 44:512-21.10.1194/jlr.M200407-JLR20012562831
  25. 25. Terkeltaub R. Gout: a variable inflammatory disease. Ann Rheum Dis. 2016; 75(2):30.10.1136/annrheumdis-2016-eular.3326
  26. 26. Zamudio-Cuevas Y, Hernández-Díaz C, Pineda C et al. Molecular basis of oxidative stress in gouty arthropathy. Clin Rheumatol. 2015(10):1667-72.10.1007/s10067-015-2933-y25854697
  27. 27. Stamp LK, Turner R, Khalilova IS et al. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricemia. Rheumatology 53(11):1958-1965.10.1093/rheumatology/keu21824899662
  28. 28. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric aicd and oxidative stress. Curr Pharm Des. 2005; 11(32):4145-51.10.2174/13816120577491325516375736
DOI: https://doi.org/10.2478/amb-2019-0028 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 37 - 43
Submitted on: Jul 1, 2019
Accepted on: Jul 1, 2019
Published on: Oct 15, 2019
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 R. Gancheva, A. Kundurdjiev, G. Nikolova, M. Ivanova, T. Kundurdjiev, Z. Kolarov, V. Gadjeva, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.